MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1183/16000617.0021-2023

Медицинская библиотека · European respiratory review : an official journal of the European Respiratory Society · 2023

Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis.

Dhana Ashar, Gupta Rishi K, Hamada Yohhei, Kengne Andre P, Kerkhoff Andrew D, Yoon Christina, Cattamanchi Adithya, Reeve Byron W P, Theron Grant, Ndlangalavu Gcobisa, Wood Robin, Drain Paul K, Calderwood Claire J, Noursadeghi Mahdad, Boyles Tom, Meintjes Graeme, Maartens Gary, Barr David A

Систематический обзорМетаанализСтатьяПеревод в очереди

Аннотация

BACKGROUND

The World Health Organization (WHO) recommends that outpatient people living with HIV (PLHIV) undergo tuberculosis screening with the WHO four-symptom screen (W4SS) or C-reactive protein (CRP) (5 mg·L-1 cut-off) followed by confirmatory testing if screen positive. We conducted an individual participant data meta-analysis to determine the performance of WHO-recommended screening tools and two newly developed clinical prediction models (CPMs).

METHODS

Following a systematic review, we identified studies that recruited adult outpatient PLHIV irrespective of tuberculosis signs and symptoms or with a positive W4SS, evaluated CRP and collected sputum for culture. We used logistic regression to develop an extended CPM (which included CRP and other predictors) and a CRP-only CPM. We used internal-external cross-validation to evaluate performance.

RESULTS

We pooled data from eight cohorts (n=4315 participants). The extended CPM had excellent discrimination (C-statistic 0.81); the CRP-only CPM had similar discrimination. The C-statistics for WHO-recommended tools were lower. Both CPMs had equivalent or higher net benefit compared with the WHO-recommended tools. Compared with both CPMs, CRP (5 mg·L-1 cut-off) had equivalent net benefit across a clinically useful range of threshold probabilities, while the W4SS had a lower net benefit. The W4SS would capture 91% of tuberculosis cases and require confirmatory testing for 78% of participants. CRP (5 mg·L-1 cut-off), the extended CPM (4.2% threshold) and the CRP-only CPM (3.6% threshold) would capture similar percentages of cases but reduce confirmatory tests required by 24, 27 and 36%, respectively.

CONCLUSIONS

CRP sets the standard for tuberculosis screening among outpatient PLHIV. The choice between using CRP at 5 mg·L-1 cut-off or in a CPM depends on available resources.

Для цитирования: Dhana Ashar, Gupta Rishi K, Hamada Yohhei, Kengne Andre P, Kerkhoff Andrew D, Yoon Christina, Cattamanchi Adithya, Reeve Byron W P, Theron Grant, Ndlangalavu Gcobisa, Wood Robin, Drain Paul K, Calderwood Claire J, Noursadeghi Mahdad, Boyles Tom, Meintjes Graeme, Maartens Gary, Barr David A. Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis.. European respiratory review : an official journal of the European Respiratory Society. 2023. DOI: 10.1183/16000617.0021-2023.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.